Plain-English translation of NCT07123038 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a long-term follow-up study for people who participated in earlier clinical trials of SBT777101, a gene-modified immune cell therapy. Researchers want to monitor your health for up to 15 years after you received the treatment to make sure there are no delayed or long-term side effects. This type of extended monitoring is important for newer cell therapies to ensure safety over time.
Gene-modified cell therapies are relatively new treatments, and doctors need to understand how safe they are over many years after a patient receives them. This study exists to catch any delayed side effects that might develop months or years later, which helps protect future patients and gives current patients important health information.
You likely qualify if…
You likely don't qualify if…
As a participant, you would attend follow-up visits at a clinic according to a schedule set by the research team—these visits will occur over up to 15 years after your original treatment. During these visits, doctors will check on your overall health and watch for any delayed side effects from the immune cell therapy. The study is purely observational, meaning the researchers are watching and monitoring rather than giving you new treatments.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States